A Prospective, Single Arm, Single Center, Phase II Clinical Trial of Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell
Latest Information Update: 05 Aug 2022
At a glance
- Drugs Camrelizumab (Primary) ; Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 26 Aug 2020 New trial record